Drug recall · January 23, 2013
Divalproex Sodium Delayed-Release Tablets recall
Why: Labeling: Label Error On Declared Strength; Some bottles of product were missing the color-coded strength on the primary display panel of the label.
Class III: unlikely to cause harm, but breaks the rules (for example a labeling error).
The recall
- Product
Divalproex Sodium Delayed-Release Tablets, USP, 500 mg Valproic Acid Activity, 100-count tablets per bottle, Rx only, Manufactured by Upsher-Smith Laboratories, Inc., Minneapolis, MN 55447, NDC 0245-0182-11.
- Lots / codes
Lot #: 310162, Exp 09/14
- Quantity
- 11,316 bottles
- Company
- Upsher Smith Laboratories, Inc., Maple Grove, MN
- Distribution
- Nationwide and Puerto Rico
- Initiated
- December 10, 2012 · Voluntary: Firm initiated
- Classified
- January 16, 2013
- Reported
- January 23, 2013
- Ended
- November 19, 2013
- How notified
- Telephone
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.